Status:
COMPLETED
Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With DLBCL
Lead Sponsor:
University Hospital, Saarland
Conditions:
DLBCL
Old Age; Debility
Eligibility:
All Genders
80+ years
Brief Summary
Multi-center retrospective analysis of patients with DLBCL aged ≥80 years old treated with R-CHOP-14 compared to other regimens. Patient data including baseline characteristics, histology, dose intens...
Eligibility Criteria
Inclusion
- histologically proven, untreated diffus large B-cell lymphoma (DLBCL)
- diagnosis between 2005 - 2019
- age ≥80 at diagnosis
Exclusion
- \- diagnosis revision at a later timepoint
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT06150053
Start Date
July 1 2018
End Date
November 1 2023
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saarland University Medical Center
Homburg, Saarland, Germany, 66424